Compare AbbVie Inc (ABBV) vs Allegion PLC (ALLE) Price & Performance

AbbVie IncTrade

Allegion PLCTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Allegion PLC — how do they compare? AbbVie Inc trades at $248.12 (market cap $441.94B), while Allegion PLC trades at $168.66 (market cap $14.32B). The key difference: AbbVie Inc is far larger — about 30.9× Allegion PLC's market cap, and AbbVie Inc pays the higher dividend (2.77%). Which is the better fit depends on your goals.

	ABBV	ALLE
Market Cap	$441.94B	$14.32B
Sector	Health	Industrials
52-Week High	$263.58	$179.77
52-Week Low	$197.38	$125.65
Enterprise Value	$506.19B	$16.03B
Dividend Yield	2.77%	1.26%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Allegion PLC

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 23 hours agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

ALLE

View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Allegion PLC

Allegion is a global security products company with a portfolio of leading brands, such as Schlage, von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2021, Allegion generated 68% of sales in the United States. The company mainly competes with Swedish-based Assa Abloy AB and Switzerland-based Dormakaba.